Gritstone Oncology to Host Event with Oncology Key Opinion Leaders Discussing Neoantigen-based Immunotherapy During ASCO Annual Meeting

World News: . []

EMERYVILLE, Calif., May 30, 2019 (GLOBE NEWSWIRE) -- (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced that it will webcast an event with key opinion leaders who will present on neoantigen-based immunotherapy on Monday, June 3, 2019 from 6:30-8:00 a.m. CT in Chicago.

Agenda:

A live audio webcast will be available within the Investors & Media section of the Gritstone Oncology website at . An archived replay will be accessible for 30 days following the event.

Investors: Alexandra Santos Wheelhouse Life Science Advisors (510) 871-6161

More news and information about Gritstone Oncology, Inc

Published By:

Globe Newswire: 13:00 GMT Thursday 30th May 2019

Published: .

Search for other references to "gritstone" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us